author-photo

Jiayu Ling

Sun Yat-sen University

40

Papers

92

Citations

Citation Trend

Filter By

Papers (29) Sort By

Journal Conference Others

Comparison of outcomes between neoadjuvant imatinib and upfront surgery in patients with localized rectal GIST: An inverse probability of treatment weighting analysis.

2021 Journal of Surgical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Clinicopathologic features and impact of metastasectomy in patients with BRAF-mutant metastatic colorectal cancer.

2021 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Neoadjuvant PD-1 blockade with toripalimab, with or without celecoxib, in mismatch repair-deficient or microsatellite instability-high, locally advanced, colorectal cancer (PICC): a single-centre, parallel-group, non-comparative, randomised, phase 2 trial.

2021 The Lancet Gastroenterology & Hepatology
Show All
- Source
- Cite
- Save
Citations (2)
mFOLFOXIRI versus mFOLFOX6 as neoadjuvant chemotherapy in locally advanced rectal cancer: A Propensity Score Matching Analysis

2021 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Mucinous Adenocarcinoma Predicts Poor Response and Prognosis in Patients With Locally Advanced Rectal Cancer: A Pooled Analysis of Individual Participant Data From 3 Prospective Studies.

2021 Clinical Colorectal Cancer
Show All
- Source
- Cite
- Save
Citations (0)
Induction chemotherapy with mFOLFOXIRI in cT4N+ locally advanced rectal cancer: Subgroup analysis from a prospective trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Gene Expression Signature to Predict Prognosis and Adjuvant Chemosensitivity of Colorectal Cancer Patients

2020 Cancer management and research
Show All
- Source
- Cite
- Save
Citations (2)
mFOLFOXIRI with or without cetuximab as conversion therapy in patients with RAS/BRAF wild-type unresectable liver metastases colorectal cancer: The FOCULM study.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (0)
Efficacy and Safety of Regorafenib in Combination with Chemotherapy as Second-Line Treatment in Patients with Metastatic Colorectal Cancer: A Network Meta-Analysis and Systematic Literature Review

2020 Advances in Therapy
Show All
- Source
- Cite
- Save
Citations (2)
PD-1 blockade combined with COX inhibitor in patients with MSI-H/dMMR or high TMB, advanced or metastatic colorectal cancer (PCOX study).

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (1)